Last 12 months
Inside the activity.
0 purchase rows · 21 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2025 Filed Sep 4, 2025 20:27 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 51,562 | $2.50 | $128,740.00 |
DisclosureSEC source: 0001415889-25-023670 · form4-09042025_080945.xml · nonDerivative · entry 1 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,350,220 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.30 to $2.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. F3 · balance_after: The reported amount excludes 150,000 shares previously reported as performance share units, or PSUs. Because the performance metrics were not attained during the PSU measurement period, these PSUs were forfeited on May 6, 2025. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 20:33 UTC |
Wong-Sarad GracePrincipal Accounting Officer
|
SaleCommon Stock | 5,910 | $2.50 | $14,756.09 |
DisclosureSEC source: 0001415889-25-023686 · form4-09042025_080941.xml · nonDerivative · entry 1 Wong-Sarad Grace · CIK 0002074667 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,448 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.30 to $2.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 20:32 UTC |
Berkley Neil LindsayPrincipal Financial Officer
|
SaleCommon Stock | 15,842 | $2.50 | $39,554.31 |
DisclosureSEC source: 0001415889-25-023683 · form4-09042025_080917.xml · nonDerivative · entry 1 Berkley Neil Lindsay · CIK 0002075298 · Principal Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,570 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.30 to $2.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| August 26, 2025 Filed Aug 27, 2025 22:37 UTC |
Hammond PaulaDirector
|
SaleCommon Stock | 14,000 | $2.36 | $32,998.00 |
DisclosureSEC source: 0001415889-25-023187 · form4-08272025_100849.xml · nonDerivative · entry 1 Hammond Paula · CIK 0001805348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,909 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 27, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.31 to $2.385. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| July 01, 2025 Filed Jul 1, 2025 21:00 UTC |
Kenkare-Mitra SaraPresident and Head of R&D
|
GrantEmployee Stock Option (right to buy) · Derivative | 18,250 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0000950170-25-092313 · ownership.xml · derivative · entry 2 Kenkare-Mitra Sara · CIK 0001895592 · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,250 Underlying: Common Stock · 18,250 shares Expires 2035-07-01 F2 · derivative.exercise_date: One third (1/3rd) of the total shares subject to the option shall vest on November 1, 2025, and one twelfth (1/12th) of the total shares subject to the option shall vest in equal monthly installments thereafter, provided that the shares subject to the option will vest in full on July 1, 2026. Read SEC document |
| July 01, 2025 Filed Jul 1, 2025 21:00 UTC |
Kenkare-Mitra SaraPresident and Head of R&D
|
GrantCommon Stock | 54,725 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-092313 · ownership.xml · nonDerivative · entry 1 Kenkare-Mitra Sara · CIK 0001895592 · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 566,977 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, one half (1/2) of the total shares shall vest on December 1, 2025 and one fourth (1/4th) of the total shares shall vest quarterly thereafter. Read SEC document |
| July 01, 2025 Filed Jul 1, 2025 21:00 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 45,700 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0000950170-25-092312 · ownership.xml · derivative · entry 6 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,700 Underlying: Common Stock · 45,700 shares Expires 2035-07-01 F6 · derivative.exercise_date: One third (1/3rd) of the total shares subject to the option shall vest on November 1, 2025, and one twelfth (1/12th) of the total shares subject to the option shall vest in equal monthly installments thereafter, provided that the shares subject to the option will vest in full on July 1, 2026. Read SEC document |
| July 01, 2025 Filed Jul 1, 2025 21:00 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
GrantCommon Stock | 137,125 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-092312 · ownership.xml · nonDerivative · entry 1 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,551,782 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, one half (1/2) of the total shares shall vest on December 1, 2025 and one fourth (1/4th) of the total shares shall vest quarterly thereafter. Read SEC document |
| July 01, 2025 Filed Jul 1, 2025 21:00 UTC |
Berkley Neil LindsayPrincipal Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0000950170-25-092314 · ownership.xml · derivative · entry 1 Berkley Neil Lindsay · CIK 0002075298 · Principal Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2035-07-01 F1 · derivative.exercise_date: One third (1/3rd) of the total shares subject to the option shall vest on November 1, 2025, and one twelfth (1/12th) of the total shares subject to the option shall vest in equal monthly installments thereafter, provided that the shares subject to the option will vest in full on July 1, 2026. Read SEC document |
| June 20, 2025 Filed Jun 23, 2025 20:05 UTC |
Yaffe KristineDirector
|
SaleCommon Stock | 1,000 | $1.44 | $1,440.00 |
DisclosureSEC source: 0000950170-25-088968 · ownership.xml · nonDerivative · entry 1 Yaffe Kristine · CIK 0001783895 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,409 Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 22:05 UTC |
Hammond PaulaDirector
|
GrantStock Option (right to buy) · Derivative | 9,450 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0000950170-25-085620 · ownership.xml · derivative · entry 2 Hammond Paula · CIK 0001805348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,450 Underlying: Common Stock · 9,450 shares Expires 2035-06-10 F2 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 11, 2025, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 22:05 UTC |
Hammond PaulaDirector
|
GrantCommon Stock | 28,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-085620 · ownership.xml · nonDerivative · entry 1 Hammond Paula · CIK 0001805348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,909 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 22:05 UTC |
Altmeyer MarkDirector
|
GrantStock Option (right to buy) · Derivative | 9,450 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0000950170-25-085614 · ownership.xml · derivative · entry 2 Altmeyer Mark · CIK 0001643074 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,450 Underlying: Common Stock · 9,450 shares Expires 2035-06-10 F2 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 11, 2025, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 22:05 UTC |
Altmeyer MarkDirector
|
GrantCommon Stock | 28,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-085614 · ownership.xml · nonDerivative · entry 1 Altmeyer Mark · CIK 0001643074 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,950 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 22:05 UTC |
DESOUZA ERROL BDirector
|
GrantStock Option (right to buy) · Derivative | 9,450 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0000950170-25-085615 · ownership.xml · derivative · entry 2 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,450 Underlying: Common Stock · 9,450 shares Expires 2035-06-10 F2 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 11, 2025, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 22:05 UTC |
DESOUZA ERROL BDirector
|
GrantCommon Stock | 28,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-085615 · ownership.xml · nonDerivative · entry 1 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,950 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 22:05 UTC |
LAVIGNE LOUIS J JRDirector
|
GrantStock Option (right to buy) · Derivative | 9,450 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0000950170-25-085616 · ownership.xml · derivative · entry 3 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,450 Underlying: Common Stock · 9,450 shares Expires 2035-06-10 F3 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 11, 2025, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 22:05 UTC |
LAVIGNE LOUIS J JRDirector
|
GrantCommon Stock | 28,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-085616 · ownership.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,409 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 22:05 UTC |
SCHELLER RICHARD HDirector
|
GrantStock Option (right to buy) · Derivative | 9,450 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0000950170-25-085617 · ownership.xml · derivative · entry 2 SCHELLER RICHARD H · CIK 0001214133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,450 Underlying: Common Stock · 9,450 shares Expires 2035-06-10 F2 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 11, 2025, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 22:05 UTC |
SCHELLER RICHARD HDirector
|
GrantCommon Stock | 28,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-085617 · ownership.xml · nonDerivative · entry 1 SCHELLER RICHARD H · CIK 0001214133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,366 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 22:05 UTC |
GAROFALO ELIZABETH A.Director
|
GrantStock Option (right to buy) · Derivative | 9,450 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0000950170-25-085618 · ownership.xml · derivative · entry 2 GAROFALO ELIZABETH A. · CIK 0001826361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,450 Underlying: Common Stock · 9,450 shares Expires 2035-06-10 F2 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 11, 2025, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 22:05 UTC |
GAROFALO ELIZABETH A.Director
|
GrantCommon Stock | 28,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-085618 · ownership.xml · nonDerivative · entry 1 GAROFALO ELIZABETH A. · CIK 0001826361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,950 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 22:05 UTC |
Yaffe KristineDirector
|
GrantStock Option (right to buy) · Derivative | 9,450 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0000950170-25-085619 · ownership.xml · derivative · entry 2 Yaffe Kristine · CIK 0001783895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,450 Underlying: Common Stock · 9,450 shares Expires 2035-06-10 F2 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 11, 2025, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 22:05 UTC |
Yaffe KristineDirector
|
GrantCommon Stock | 28,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-085619 · ownership.xml · nonDerivative · entry 1 Yaffe Kristine · CIK 0001783895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,409 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:19 UTC |
Kenkare-Mitra SaraPresident and Head of R&D
|
SaleCommon Stock | 23,890 | $1.34 | $31,974.38 |
DisclosureSEC source: 0001415889-25-015585 · form4-06042025_080634.xml · nonDerivative · entry 1 Kenkare-Mitra Sara · CIK 0001895592 · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 512,252 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.285 to $1.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:18 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 52,087 | $1.34 | $69,713.24 |
DisclosureSEC source: 0001415889-25-015583 · form4-06042025_080624.xml · nonDerivative · entry 1 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,414,657 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.285 to $1.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:21 UTC |
GRASSO MARCChief Financial Officer
|
SaleCommon Stock | 16,488 | $1.34 | $22,067.54 |
DisclosureSEC source: 0001415889-25-015591 · form4-06042025_080614.xml · nonDerivative · entry 1 GRASSO MARC · CIK 0001748894 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 296,072 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.285 to $1.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| May 02, 2025 Filed May 2, 2025 22:00 UTC |
SCHELLER RICHARD HDirector
|
GrantCommon Stock | 15,833 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-062995 · ownership.xml · nonDerivative · entry 1 SCHELLER RICHARD H · CIK 0001214133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,666 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in 4 equal quarterly installments beginning on June 1, 2025. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:05 UTC |
Kenkare-Mitra SaraPresident and Head of R&D
|
SaleCommon Stock | 29,073 | $1.47 | $42,661.72 |
DisclosureSEC source: 0000950170-25-033534 · ownership.xml · nonDerivative · entry 1 Kenkare-Mitra Sara · CIK 0001895592 · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 536,142 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.4673 to $1.4676. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 16:05 UTC |
Romano GaryChief Medical Officer
|
SaleCommon Stock | 16,306 | $1.47 | $23,927.42 |
DisclosureSEC source: 0000950170-25-033520 · ownership.xml · nonDerivative · entry 1 Romano Gary · CIK 0001799779 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 332,977 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.4673 to $1.4686. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:05 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 40,330 | $1.47 | $59,176.21 |
DisclosureSEC source: 0000950170-25-033530 · ownership.xml · nonDerivative · entry 1 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,466,744 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.4673 to $1.4674. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:05 UTC |
GRASSO MARCChief Financial Officer
|
SaleCommon Stock | 18,091 | $1.47 | $26,546.73 |
DisclosureSEC source: 0000950170-25-033539 · ownership.xml · nonDerivative · entry 1 GRASSO MARC · CIK 0001748894 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 312,560 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.4673 to $1.4678. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 22:40 UTC |
Kenkare-Mitra SaraPresident and Head of R&D
|
SaleCommon Stock | 26,500 | $2.52 | $66,764.10 |
DisclosureSEC source: 0000950170-24-132911 · ownership.xml · nonDerivative · entry 1 Kenkare-Mitra Sara · CIK 0001895592 · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 565,215 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.5193 to $2.5194. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 17:40 UTC |
Romano GaryChief Medical Officer
|
SaleCommon Stock | 14,892 | $2.52 | $37,518.90 |
DisclosureSEC source: 0000950170-24-132910 · ownership.xml · nonDerivative · entry 1 Romano Gary · CIK 0001799779 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,283 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.5194 to $2.5197. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 22:40 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 52,172 | $2.52 | $131,442.14 |
DisclosureSEC source: 0000950170-24-132912 · ownership.xml · nonDerivative · entry 1 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,507,074 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.5193 to $2.5194. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 22:40 UTC |
GRASSO MARCChief Financial Officer
|
SaleCommon Stock | 16,489 | $2.52 | $41,542.39 |
DisclosureSEC source: 0000950170-24-132913 · ownership.xml · nonDerivative · entry 1 GRASSO MARC · CIK 0001748894 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,651 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.5193 to $2.5195. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:05 UTC |
Kenkare-Mitra SaraPresident and Head of R&D
|
GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-111422 · ownership.xml · nonDerivative · entry 1 Kenkare-Mitra Sara · CIK 0001895592 · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 591,715 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in 12 equal quarterly installments beginning on December 1, 2024. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 16:05 UTC |
Romano GaryChief Medical Officer
|
GrantCommon Stock | 184,380 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-111419 · ownership.xml · nonDerivative · entry 1 Romano Gary · CIK 0001799779 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 364,175 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in 12 equal quarterly installments beginning on December 1, 2024. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:05 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
GrantCommon Stock | 610,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-111421 · ownership.xml · nonDerivative · entry 1 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,559,246 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in 12 equal quarterly installments beginning on December 1, 2024. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:05 UTC |
GRASSO MARCChief Financial Officer
|
GrantCommon Stock | 216,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-111426 · ownership.xml · nonDerivative · entry 1 GRASSO MARC · CIK 0001748894 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 347,140 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in 12 equal quarterly installments beginning on December 1, 2024. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 20:15 UTC |
Kenkare-Mitra SaraPresident and Head of R&D
|
SaleCommon Stock | 13,926 | $4.88 | $67,981.16 |
DisclosureSEC source: 0000950170-24-103407 · ownership.xml · nonDerivative · entry 1 Kenkare-Mitra Sara · CIK 0001895592 · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,715 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.8815 to $4.8818. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 16:15 UTC |
Romano GaryChief Medical Officer
|
SaleCommon Stock | 8,478 | $4.88 | $41,385.36 |
DisclosureSEC source: 0000950170-24-103406 · ownership.xml · nonDerivative · entry 1 Romano Gary · CIK 0001799779 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,795 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.8814 to $4.8820. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 20:15 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 26,499 | $4.88 | $129,386.67 |
DisclosureSEC source: 0000950170-24-103408 · ownership.xml · nonDerivative · entry 1 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,948,746 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.8827 to $4.8828. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 20:44 UTC |
GRASSO MARCChief Financial Officer
|
SaleCommon Stock | 7,297 | $4.88 | $35,620.31 |
DisclosureSEC source: 0000950170-24-103454 · ownership.xml · nonDerivative · entry 1 GRASSO MARC · CIK 0001748894 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,740 F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.8815 to $4.8816. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| August 22, 2024 Filed Aug 23, 2024 20:05 UTC |
SCHELLER RICHARD HDirector
|
SaleCommon Stock | 44,250 | $5.16 | $228,387.53 |
DisclosureSEC source: 0000950170-24-100168 · ownership.xml · nonDerivative · entry 1 SCHELLER RICHARD H · CIK 0001214133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.045 to $5.230. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 23:55 UTC |
Hammond PaulaDirector
|
SaleCommon Stock | 10,500 | $5.06 | $53,179.35 |
DisclosureSEC source: 0000950170-24-096566 · ownership.xml · nonDerivative · entry 1 Hammond Paula · CIK 0001805348 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,209 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 10, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.005 to $5.160. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 23:55 UTC |
Yaffe KristineDirector
|
SaleCommon Stock | 5,000 | $5.06 | $25,309.00 |
DisclosureSEC source: 0000950170-24-096565 · ownership.xml · nonDerivative · entry 1 Yaffe Kristine · CIK 0001783895 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,709 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 10, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.01 to $5.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. Read SEC document |
| August 02, 2024 Filed Oct 10, 2024 20:05 UTC |
SCHELLER RICHARD HDirector
|
GrantCommon Stock | 15,833 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-114050 · ownership.xml · nonDerivative · entry 1 SCHELLER RICHARD H · CIK 0001214133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,833 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in 4 equal quarterly installments beginning on September 1, 2024. F2 · balance_after: The reported amounts in Column 5 of Table I reflect the Reporting Person's beneficial ownership as of the date of filing this Form 4. Read SEC document |
| June 12, 2024 Filed Jun 12, 2024 20:46 UTC |
Hammond PaulaDirector
|
GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-072513 · ownership.xml · nonDerivative · entry 1 Hammond Paula · CIK 0001805348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,709 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 12, 2025 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 12, 2024 Filed Jun 12, 2024 20:46 UTC |
LAVIGNE LOUIS J JRDirector
|
GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-072518 · ownership.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,709 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 12, 2025 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.